A Peter Mansell-chaired cancer research trust has cashed in its shareholding in Sydney-based Sirtex Medical, netting $20.6 million from the sale.
A Peter Mansell-chaired cancer research trust has cashed in its shareholding in Sydney-based Sirtex Medical, netting $20.6 million from the sale.